HMS Holdings Corp.’s Investment in MedAdvisor

Baker McKenzie acted for the Nasdaq listed HMS Holdings Corp., on its 13% stake investment in the ASX-listed MedAdvisor.

HMS Holdings Corporation operates as a holding company. The Company, through its subsidiaries, provides proprietary information management and data processing products and services. HMS Holdings markets its products to hospitals and health care providers, government health service agencies, payers and purchasers of health care, and companies serving the health care industry.

MedAdvisor Limited designs and develops application software. The Company offers software solutions that empowers individuals and carers to manage all aspects of prescription medication use. MedAdvisor serves customers in Australia.

Baker McKenzie team included Richard Lustig (Picture), Xavier Keary and Ben McLaughlin.

Involved fees earner: Xavier Keary – Baker McKenzie; Richard Lustig – Baker McKenzie; Ben McLaughlin – Baker McKenzie;

Law Firms: Baker McKenzie;

Clients: HMS Holdings;

Author: Michael Patrini